Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard Haubrich

Showing results (61-70 of 109) with videos related to

Pageof 11
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 1, 2021
Remdesivir Treatment in Hospitalized Patients With Coronavirus Disease 2019 (COVID-19): A Comparative Analysis of In-hospital All-cause Mortality in a Large Multicenter Observational CohortEssy Mozaffari, Aastha Chandak, Zhiji Zhang, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 17, 2010
Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifsMina John, David Heckerman, Ian James, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 15, 2013
Low baseline CD4+ count is associated with greater bone mineral density loss after antiretroviral therapy initiationPhilip M Grant, Douglas Kitch, Grace A McComsey, et al.
BMC Pediatrics|November 27, 2012
High prevalence of lipoatrophy in pre-pubertal South African children on antiretroviral therapy: a cross-sectional studySteve Innes, Mark F Cotton, Richard Haubrich, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|July 26, 2012
Metabolic syndrome before and after initiation of antiretroviral therapy in treatment-naive HIV-infected individualsSupriya Krishnan, Jeffrey T Schouten, Benjamin Atkinson, et al.
Antiviral Research|April 29, 2014
Maraviroc intensification in patients with suppressed HIV viremia has limited effects on CD4+ T cell recovery and gene expressionNadejda Beliakova-Bethell, Sonia Jain, Christopher H Woelk, et al.
Medicine|April 7, 2017
Comparative effectiveness of single versus multiple tablet antiretroviral therapy regimens in clinical HIV practiceDaniel R Drozd, Michael S Saag, Andrew O Westfall, et al.
Pacific Symposium on Biocomputing. Pacific Symposium on Biocomputing|December 2, 2010
Use of biological knowledge to inform the analysis of gene-gene interactions involved in modulating virologic failure with efavirenz-containing treatment regimens in ART-naïve ACTG clinical trials participantsBenjamin J Grady, Eric S Torstenson, Paul J McLaren, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 13, 2012
Characterizing HIV transmission networks across the United StatesJeannette L Aldous, Sergei Kosakovsky Pond, Art Poon, et al.
Lancet (London, England)|July 10, 2007
Efficacy and safety of TMC125 (etravirine) in treatment-experienced HIV-1-infected patients in DUET-1: 24-week results from a randomised, double-blind, placebo-controlled trialJosé Valdez Madruga, Pedro Cahn, Beatriz Grinsztejn, et al.
Pageof 11

Showing results (61-70 of 109) with videos related to

Sort By:
Pageof 11
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 1, 2021
Remdesivir Treatment in Hospitalized Patients With Coronavirus Disease 2019 (COVID-19): A Comparative Analysis of In-hospital All-cause Mortality in a Large Multicenter Observational CohortEssy Mozaffari, Aastha Chandak, Zhiji Zhang, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 17, 2010
Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifsMina John, David Heckerman, Ian James, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 15, 2013
Low baseline CD4+ count is associated with greater bone mineral density loss after antiretroviral therapy initiationPhilip M Grant, Douglas Kitch, Grace A McComsey, et al.
BMC Pediatrics|November 27, 2012
High prevalence of lipoatrophy in pre-pubertal South African children on antiretroviral therapy: a cross-sectional studySteve Innes, Mark F Cotton, Richard Haubrich, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|July 26, 2012
Metabolic syndrome before and after initiation of antiretroviral therapy in treatment-naive HIV-infected individualsSupriya Krishnan, Jeffrey T Schouten, Benjamin Atkinson, et al.
Antiviral Research|April 29, 2014
Maraviroc intensification in patients with suppressed HIV viremia has limited effects on CD4+ T cell recovery and gene expressionNadejda Beliakova-Bethell, Sonia Jain, Christopher H Woelk, et al.
Medicine|April 7, 2017
Comparative effectiveness of single versus multiple tablet antiretroviral therapy regimens in clinical HIV practiceDaniel R Drozd, Michael S Saag, Andrew O Westfall, et al.
Pacific Symposium on Biocomputing. Pacific Symposium on Biocomputing|December 2, 2010
Use of biological knowledge to inform the analysis of gene-gene interactions involved in modulating virologic failure with efavirenz-containing treatment regimens in ART-naïve ACTG clinical trials participantsBenjamin J Grady, Eric S Torstenson, Paul J McLaren, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 13, 2012
Characterizing HIV transmission networks across the United StatesJeannette L Aldous, Sergei Kosakovsky Pond, Art Poon, et al.
Lancet (London, England)|July 10, 2007
Efficacy and safety of TMC125 (etravirine) in treatment-experienced HIV-1-infected patients in DUET-1: 24-week results from a randomised, double-blind, placebo-controlled trialJosé Valdez Madruga, Pedro Cahn, Beatriz Grinsztejn, et al.
Pageof 11